Model
Edge
Moonlake Immunotherapeutics
0001920785
Filing Type
4
Filing Date
6/6/2024
Updated
6/7/24, 2:59 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership